Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 159

1.

Histological complete response to a combined docetaxel/cisplatin/fluorouracil neoadjuvant chemotherapy for T4 stage gastric adenocarcinoma.

Guo Mg, Zheng Q, zhong Di J, Yang Z.

World J Surg Oncol. 2014 May 19;12:150. doi: 10.1186/1477-7819-12-150.

2.

The combination of docetaxel and cisplatin plus fluorouracil as neoadjuvant chemotherapy in the treatment of T4 stage gastric cancer.

Guo MG, Zheng Q, Cheng Z, Wang Y, Feng CN, Yang Z.

Surg Oncol. 2010 Mar;19(1):1-3. doi: 10.1016/j.suronc.2008.10.001. Epub 2008 Nov 8.

PMID:
19006661
3.

Neoadjuvant chemotherapy with a combination of docetaxel, cisplatin, fluorouracil, and leucovorin in nonresectable advanced gastric cancer: a short communication.

Ma Y, Qin H, Zheng Q, Wang Y, Wang Z, Yang Z.

Med Oncol. 2010 Dec;27(4):1089-95. doi: 10.1007/s12032-009-9340-7. Epub 2009 Nov 3.

PMID:
19885749
5.

Docetaxel, cisplatin, and fluorouracil combination in neoadjuvant setting in the treatment of locally advanced gastric adenocarcinoma: Phase II NEOTAX study.

Ozdemir N, Abali H, Vural M, Yalcin S, Oksuzoglu B, Civelek B, Oguz D, Bostanci B, Yalcin B, Zengin N.

Cancer Chemother Pharmacol. 2014 Dec;74(6):1139-47. doi: 10.1007/s00280-014-2586-6. Epub 2014 Sep 19. Erratum in: Cancer Chemother Pharmacol. 2015 Jul;76(1):217.

PMID:
25234436
6.

A phase I study of weekly docetaxel, 24-hour infusion of high-dose fluorouracil/leucovorin and cisplatin in patients with advanced gastric cancer.

Chen LT, Liu TW, Wu CW, Chung TR, Shiah HS, Jan CM, Liu JM, Whang-Peng J, Chang JY.

Oncology. 2002;63(3):239-47.

PMID:
12381903
7.

Preoperative docetaxel/cisplatin/5-fluorouracil chemotherapy in patients with locally advanced gastro-esophageal adenocarcinoma.

Bayraktar UD, Bayraktar S, Hosein P, Chen E, Koniaris LG, Rocha-Lima CM, Montero AJ.

Med Oncol. 2012 Sep;29(3):1707-10. doi: 10.1007/s12032-011-0093-8. Epub 2011 Oct 28.

PMID:
22033912
8.

Docetaxel, cisplatin, and fluorouracil; docetaxel and cisplatin; and epirubicin, cisplatin, and fluorouracil as systemic treatment for advanced gastric carcinoma: a randomized phase II trial of the Swiss Group for Clinical Cancer Research.

Roth AD, Fazio N, Stupp R, Falk S, Bernhard J, Saletti P, Köberle D, Borner MM, Rufibach K, Maibach R, Wernli M, Leslie M, Glynne-Jones R, Widmer L, Seymour M, de Braud F; Swiss Group for Clinical Cancer Research..

J Clin Oncol. 2007 Aug 1;25(22):3217-23.

PMID:
17664469
10.

Preoperative versus postoperative docetaxel-cisplatin-fluorouracil (TCF) chemotherapy in locally advanced resectable gastric carcinoma: 10-year follow-up of the SAKK 43/99 phase III trial.

Fazio N, Biffi R, Maibach R, Hayoz S, Thierstein S, Brauchli P, Bernhard J, Stupp R, Andreoni B, Renne G, Crosta C, Morant R, Chiappa A, Luca F, Zampino MG, Huber O, Goldhirsch A, de Braud F, Roth AD; Swiss Group for Clinical Cancer Research SAKK.; European Institute of Oncology, Milan, Italy..

Ann Oncol. 2016 Apr;27(4):668-73. doi: 10.1093/annonc/mdv620. Epub 2015 Dec 27.

PMID:
26712905
11.

[A successful resected case of advanced esophageal cancer with early gastric cancer responding to neoadjuvant chemotherapy of docetaxel, CDDP and 5-FU].

Matsutani T, Yoshida H, Sasajima K, Maruyama H, Yokoyama T, Matsushita A, Hirakata A, Takao Y, Umakoshi M, Hayakawa T, Katayama H, Hosone M, Uchida E.

Gan To Kagaku Ryoho. 2012 Apr;39(4):645-8. Japanese.

PMID:
22504694
12.

Adjuvant (cisplatin, etoposide, and 5-fluorouracil) chemotherapy after curative resection of gastric adenocarcinomas involving the esophagogastric junction.

Ryoo BY, Kang YK, Im YH, Kim YJ, Kim BS, Kim TY, Jung SH, Park JH, Baek HJ, Kim YC, Shim YM, Kim CM, Zo JI.

Am J Clin Oncol. 1999 Jun;22(3):253-7.

PMID:
10362331
13.

Neoadjuvant docetaxel, capecitabine and cisplatin (DXP) in patients with unresectable locally advanced or metastatic gastric cancer.

Sym SJ, Chang HM, Ryu MH, Lee JL, Kim TW, Yook JH, Oh ST, Kim BS, Kang YK.

Ann Surg Oncol. 2010 Apr;17(4):1024-32. doi: 10.1245/s10434-009-0838-1. Epub 2009 Nov 26.

PMID:
19941081
14.

Neoadjuvant chemotherapy with cisplatin, 5-FU, and leucovorin (PLF) in locally advanced gastric cancer: a prospective phase II study.

Ott K, Sendler A, Becker K, Dittler HJ, Helmberger H, Busch R, Kollmannsberger C, Siewert JR, Fink U.

Gastric Cancer. 2003;6(3):159-67.

PMID:
14520529
15.

Phase II multi-institutional randomized trial of docetaxel plus cisplatin with or without fluorouracil in patients with untreated, advanced gastric, or gastroesophageal adenocarcinoma.

Ajani JA, Fodor MB, Tjulandin SA, Moiseyenko VM, Chao Y, Cabral Filho S, Majlis A, Assadourian S, Van Cutsem E.

J Clin Oncol. 2005 Aug 20;23(24):5660-7.

PMID:
16110025
16.

[Preliminary study of biweekly regimen of docetaxel, oxaliplatin, 5-fluorouracil and leucovorin for advanced gastric cancer].

Wang ZH, Guo J, Chen Z, Li CZ, Sheng LJ, Zhou DG, Liu B, Liu J, Wang QC, Zhang EN.

Zhonghua Zhong Liu Za Zhi. 2008 May;30(5):389-91. Chinese.

PMID:
18953843
17.

Impact of neoadjuvant chemotherapy with PELF-protocoll versus surgery alone in the treatment of advanced gastric carcinoma.

Ruf C, Thomusch O, Goos M, Makowiec F, Illerhaus G, Ruf G.

BMC Surg. 2014 Jan 24;14:5. doi: 10.1186/1471-2482-14-5.

18.

Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group.

Van Cutsem E, Moiseyenko VM, Tjulandin S, Majlis A, Constenla M, Boni C, Rodrigues A, Fodor M, Chao Y, Voznyi E, Risse ML, Ajani JA; V325 Study Group..

J Clin Oncol. 2006 Nov 1;24(31):4991-7.

PMID:
17075117
19.

The efficacy and safety of reduced-dose docetaxel, cisplatin, and 5-fluorouracil in the first-line treatment of advanced stage gastric adenocarcinoma.

Ozdemir NY, Abali H, Oksüzoğlu B, Budakoglu B, Uncu D, Güler T, Odabaşi H, Zengin N.

Med Oncol. 2010 Sep;27(3):680-4. doi: 10.1007/s12032-009-9268-y. Epub 2009 Jul 25.

PMID:
19633962
20.

Comparison of five tumor regression grading systems for gastric adenocarcinoma after neoadjuvant chemotherapy: a retrospective study of 192 cases from National Cancer Center in China.

Zhu Y, Sun Y, Hu S, Jiang Y, Yue J, Xue X, Yang L, Xue L.

BMC Gastroenterol. 2017 Mar 14;17(1):41. doi: 10.1186/s12876-017-0598-5.

Supplemental Content

Support Center